Reuben Lotan

Title: Reuben Lotan: Innovator in Cervical Cancer Treatment

Introduction

Reuben Lotan is a notable inventor based in Kingwood, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment and prevention of cervical cancer. His innovative work focuses on the use of DFMO, a compound that shows promise in combating cervical intraepithelial neoplasia.

Latest Patents

Reuben Lotan holds a patent for "DFMO for the treatment or prevention of cervical intraepithelial." This patent outlines methods for treating, preventing, controlling the growth of, and reducing the risk of developing cervical cancer. The methods involve the use of pharmaceutically acceptable preparations of DFMO, either alone or in combination with cytotoxic or cytostatic agents. This groundbreaking approach aims to provide effective treatment options for patients suffering from cervical intraepithelial neoplasia.

Career Highlights

Lotan is affiliated with the University of Texas System, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on women's health, particularly in the early detection and treatment of cervical cancer.

Collaborations

Reuben Lotan has collaborated with esteemed colleagues, including Michele Follen and Wuan K Hong. These partnerships have further enriched his research and contributed to the development of effective treatment methodologies.

Conclusion

Reuben Lotan's contributions to the field of cervical cancer treatment through his innovative patent on DFMO highlight his dedication to improving patient outcomes. His work exemplifies the importance of research and collaboration in the fight against cancer.